RIL
TARS icon

Rothschild Investment LLC’s Tarsus Pharmaceuticals TARS Stock Holding History

Rothschild Investment LLC’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53K Buy
72
+7
+11% +$447 ﹤0.01% 2333
2026
Q1 		$4.56K Buy
65
+5
+8% +$349 ﹤0.01% 2099
2025
Q4 		$4.91K Hold
60
– – ﹤0.01% 1890
2025
Q3 		$3.57K Hold
60
– – ﹤0.01% 1876
2025
Q2 		$2.43K Sell
60
-10
-14% -$450 ﹤0.01% 1933
2025
Q1 		$3.6K Buy
70
+20
+40% +$989 ﹤0.01% 1593
2024
Q4 		$2.77K Buy
50
+10
+25% +$454 ﹤0.01% 1615
2024
Q3 		$1.32K Buy
40
+30
+300% +$843 ﹤0.01% 1969
2024
Q2 		$272 Buy
10
+5
+100% +$168 ﹤0.01% 2344
2024
Q1 		$182 Buy
+5
New +$147 ﹤0.01% 1792

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rothschild Investment LLC's TARS Position: Q2 2026 in Review

Rothschild Investment LLC increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q2 2026, buying an estimated $447 and bringing the position to 72 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Rothschild Investment LLC first reported a position in TARS in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.91K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Rothschild Investment LLC held 72 shares of Tarsus Pharmaceuticals worth $4.53K as of Q2 2026.
  • Rothschild Investment LLC bought 7 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $447.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2333 holding.
  • Rothschild Investment LLC first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Tarsus Pharmaceuticals position peaked at $4.91K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.